• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从感染到胃癌:免疫反应的当前证据

From infection to gastric cancer: Current evidence on the immune response.

作者信息

Lima de Souza Gonçalves Vinícius, Cordeiro Santos Maria Luísa, Silva Luz Marcel, Santos Marques Hanna, de Brito Breno Bittencourt, França da Silva Filipe Antônio, Souza Cláudio Lima, Oliveira Márcio Vasconcelos, de Melo Fabrício Freire

机构信息

Universidade Estadual do Sudoeste da Bahia, Campus Vitória da Conquista, Vitória da Conquista 45083-900, Bahia, Brazil.

Universidade Federal da Bahia, Instituto Multidisciplinar em Saúde, Vitória da Conquista 45029-094, Bahia, Brazil.

出版信息

World J Clin Oncol. 2022 Mar 24;13(3):186-199. doi: 10.5306/wjco.v13.i3.186.

DOI:10.5306/wjco.v13.i3.186
PMID:35433296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8966509/
Abstract

Gastric cancer (GC) is the result of a multifactorial process whose main components are infection by (), bacterial virulence factors, host immune response and environmental factors. The development of the neoplastic microenvironment also depends on genetic and epigenetic changes in oncogenes and tumor suppressor genes, which results in deregulation of cell signaling pathways and apoptosis process. This review summarizes the main aspects of the pathogenesis of GC and the immune response involved in chronic inflammation generated by .

摘要

胃癌(GC)是一个多因素过程的结果,其主要组成部分是()感染、细菌毒力因子、宿主免疫反应和环境因素。肿瘤微环境的发展还取决于癌基因和肿瘤抑制基因的遗传和表观遗传变化,这导致细胞信号通路和凋亡过程失调。本综述总结了GC发病机制的主要方面以及由()产生的慢性炎症中涉及的免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d958/8966509/499a9bb3cee1/WJCO-13-186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d958/8966509/9ebc1abb004c/WJCO-13-186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d958/8966509/499a9bb3cee1/WJCO-13-186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d958/8966509/9ebc1abb004c/WJCO-13-186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d958/8966509/499a9bb3cee1/WJCO-13-186-g002.jpg

相似文献

1
From infection to gastric cancer: Current evidence on the immune response.从感染到胃癌:免疫反应的当前证据
World J Clin Oncol. 2022 Mar 24;13(3):186-199. doi: 10.5306/wjco.v13.i3.186.
2
The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.微小 RNA 在幽门螺杆菌发病机制和胃癌发生中的作用。
Front Cell Infect Microbiol. 2012 Jan 3;1:21. doi: 10.3389/fcimb.2011.00021. eCollection 2011.
3
Host pathogen interactions in related gastric cancer.相关胃癌中的宿主-病原体相互作用
World J Gastroenterol. 2017 Mar 7;23(9):1521-1540. doi: 10.3748/wjg.v23.i9.1521.
4
TIFA Signaling in Gastric Epithelial Cells Initiates the Type 4 Secretion System-Dependent Innate Immune Response to Infection.胃上皮细胞中的TIFA信号传导启动了对感染的4型分泌系统依赖性固有免疫反应。
mBio. 2017 Aug 15;8(4):e01168-17. doi: 10.1128/mBio.01168-17.
5
Helicobacter pylori-induced gastric inflammation and gastric cancer.幽门螺杆菌引起的胃炎症和胃癌。
Cancer Lett. 2014 Apr 10;345(2):196-202. doi: 10.1016/j.canlet.2013.08.016. Epub 2013 Aug 24.
6
The TLR/MyD88 signalling cascade in inflammation and gastric cancer: the immune regulatory network of Helicobacter pylori.TLR/MyD88 信号通路在炎症和胃癌中的作用:幽门螺杆菌的免疫调节网络。
J Mol Med (Berl). 2023 Jul;101(7):767-781. doi: 10.1007/s00109-023-02332-5. Epub 2023 May 17.
7
Role of Helicobacter pylori in gastric cancer: Updates.幽门螺杆菌在胃癌中的作用:最新进展
World J Gastrointest Oncol. 2016 Feb 15;8(2):147-58. doi: 10.4251/wjgo.v8.i2.147.
8
Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.幽门螺杆菌与微小RNA:与先天免疫及癌前病变进展的关系
World J Clin Oncol. 2015 Oct 10;6(5):111-32. doi: 10.5306/wjco.v6.i5.111.
9
Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.幽门螺杆菌感染:宿主免疫反应、对基因表达和微小RNA的影响
World J Gastroenterol. 2014 Feb 14;20(6):1424-37. doi: 10.3748/wjg.v20.i6.1424.
10
Review article: the role of inflammation in the pathogenesis of gastric cancer.综述文章:炎症在胃癌发病机制中的作用
Aliment Pharmacol Ther. 1999 Mar;13 Suppl 1:13-8. doi: 10.1046/j.1365-2036.1999.00003.x.

引用本文的文献

1
Dysregulated macrophage immunity in infection: unveiling mechanistic insights and therapeutic implications.感染中巨噬细胞免疫失调:揭示机制见解与治疗意义
Front Immunol. 2025 Aug 4;16:1636768. doi: 10.3389/fimmu.2025.1636768. eCollection 2025.
2
Transforming bacterial pathogens into wonder tools in cancer immunotherapy.将细菌病原体转化为癌症免疫治疗中的神奇工具。
Mol Ther. 2025 Mar 5;33(3):866-882. doi: 10.1016/j.ymthe.2025.01.029. Epub 2025 Jan 17.
3
Developing a potent vaccine against : critical considerations and challenges.

本文引用的文献

1
Gastric cancer: Epidemiology, risk factors and prevention strategies.胃癌:流行病学、危险因素及预防策略。
Chin J Cancer Res. 2020 Dec 31;32(6):695-704. doi: 10.21147/j.issn.1000-9604.2020.06.03.
2
Tumor-Associated Macrophages in Tumor Immunity.肿瘤相关巨噬细胞在肿瘤免疫中的作用。
Front Immunol. 2020 Dec 3;11:583084. doi: 10.3389/fimmu.2020.583084. eCollection 2020.
3
Tumor-infiltrating podoplanin cells in gastric cancer: clinical outcomes and association with immune contexture.胃癌中肿瘤浸润的血小板反应蛋白1结构域7蛋白细胞:临床结局及其与免疫微环境的关联
开发针对……的有效疫苗:关键考量与挑战
Expert Rev Mol Med. 2024 Nov 25;27:e12. doi: 10.1017/erm.2024.19.
4
Oral administration of DNA alginate nanovaccine induced immune-protection against Helicobacter pylori in Balb/C mice.口服 DNA 海藻酸钠纳米疫苗诱导 Balb/C 小鼠抗幽门螺杆菌免疫保护。
BMC Immunol. 2024 Feb 3;25(1):11. doi: 10.1186/s12865-024-00602-6.
5
Prognosis and survival study in patients with gastric adenocarcinoma and its relationship with pRb expression alteration: A retrospective IHC-based study.胃腺癌患者的预后与生存研究及其与pRb表达改变的关系:一项基于免疫组化的回顾性研究。
Health Sci Rep. 2023 Jul 26;6(7):e1445. doi: 10.1002/hsr2.1445. eCollection 2023 Jul.
6
Comparative genomics of two Vietnamese Helicobacter pylori strains, CHC155 from a non-cardia gastric cancer patient and VN1291 from a duodenal ulcer patient.越南两种幽门螺杆菌菌株(CHC155 来自非贲门胃癌患者,VN1291 来自十二指肠溃疡患者)的比较基因组学研究。
Sci Rep. 2023 May 31;13(1):8869. doi: 10.1038/s41598-023-35527-4.
7
Is infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies.感染与胰腺癌有关吗?一项观察性研究的系统评价和荟萃分析。
Ther Adv Chronic Dis. 2023 Feb 13;14:20406223231155119. doi: 10.1177/20406223231155119. eCollection 2023.
8
The Role of Microorganisms in the Development of Breast Implant-Associated Anaplastic Large Cell Lymphoma.微生物在乳房植入物相关间变性大细胞淋巴瘤发生发展中的作用
Pathogens. 2023 Feb 14;12(2):313. doi: 10.3390/pathogens12020313.
9
Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications.免疫疗法在胃癌治疗中的应用:分子与临床意义
Cancers (Basel). 2022 Sep 8;14(18):4378. doi: 10.3390/cancers14184378.
Oncoimmunology. 2020 Nov 13;9(1):1845038. doi: 10.1080/2162402X.2020.1845038.
4
Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer.肿瘤纯度作为胃癌预后和免疫治疗相关特征。
Cancer Med. 2020 Dec;9(23):9052-9063. doi: 10.1002/cam4.3505. Epub 2020 Oct 8.
5
Prognostic significance of Borrmann type combined with vessel invasion status in advanced gastric cancer.Borrmann分型联合血管侵犯状态在进展期胃癌中的预后意义
World J Gastrointest Oncol. 2020 Sep 15;12(9):992-1004. doi: 10.4251/wjgo.v12.i9.992.
6
Gastric cancer.胃癌。
Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5.
7
infection: Beyond gastric manifestations.感染:超越胃部表现。
World J Gastroenterol. 2020 Jul 28;26(28):4076-4093. doi: 10.3748/wjg.v26.i28.4076.
8
Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.肿瘤内富含产生白细胞介素-10的巨噬细胞的胃癌患者的临床预后不良及免疫逃避结构
Ann Surg. 2022 Apr 1;275(4):e626-e635. doi: 10.1097/SLA.0000000000004037.
9
Tumor microenvironment in gastric cancers.胃癌中的肿瘤微环境。
Cancer Sci. 2020 Aug;111(8):2696-2707. doi: 10.1111/cas.14521. Epub 2020 Jul 11.
10
Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal.调控性髓系细胞通过代谢产物甲基乙二醛的细胞间转移使 T 细胞瘫痪。
Nat Immunol. 2020 May;21(5):555-566. doi: 10.1038/s41590-020-0666-9. Epub 2020 Apr 23.